InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Hernday Natasha. Director active across 3 companies, notably XOMA Corp. Cumulatively, 7 disclosures have been logged. Activity tracked since 15 May 2024. The latest transaction was filed on 11 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Hernday Natasha is a declarant linked to XOMA Royalty Corp, Janux Therapeutics, Inc. and XOMA Corp as a Director. The record shows 7 filings in total, and within the sampled recent filings the period runs from 2024-05-17 to 2026-07-14, with the dominant transaction nature listed as Attribution. Buy and sell amounts are both 0 EUR in this recent sample.